The top 10 drugs losing U.S. exclusivity in 2021

The top 10 drugs losing U.S. exclusivity in 2021

Source: 
Fierce Pharma
snippet: 

As drugmakers respond to the COVID-19 pandemic by developing vaccines and therapeutics, many of them are losing patent protection on older—and once lucrative—medicines. Each year, many of the pharmaceutical industry’s stalwart products lose their exclusive hold on the market, offering an opportunity for generics makers to seize share with cheaper copycats.